LRINEC Score Calculator – Necrotizing Fasciitis Risk Assessment

Clinical calculation support · Verify results before clinical use

Laboratory Parameters

All six laboratory values are required to calculate a complete score.

— Score / 13
01

C-reactive protein (CRP)

Serum CRP concentration.

0 or 4 points
mg/L

Below 150 mg/L = 0; 150 mg/L or higher = 4 points.

02

Total white blood cell count

Total leukocyte count.

0–2 points
×10⁹/L

Below 15 = 0; 15–25 inclusive = 1; above 25 = 2 points.

03

Hemoglobin

Blood hemoglobin concentration.

0–2 points
g/dL

Above 13.5 = 0; 11–13.5 inclusive = 1; below 11 = 2 points.

04

Serum sodium

Serum sodium concentration.

0 or 2 points
mmol/L

135 mmol/L or higher = 0; below 135 = 2 points.

05

Serum creatinine

Serum creatinine concentration.

0 or 2 points
µmol/L

141 µmol/L or lower = 0; above 141 = 2 points.

06

Serum glucose

Serum glucose concentration.

0 or 1 point
mmol/L

10 mmol/L or lower = 0; above 10 = 1 point.

About the LRINEC Score

The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score was developed to help distinguish necrotizing fasciitis from other severe soft-tissue infections using six routinely available laboratory parameters. The original score ranges from 0 to 13.

This calculator implements the original Wong et al. laboratory thresholds. Risk bands are displayed as low (0–5), intermediate (6–7), and high (8–13), consistent with commonly reproduced LRINEC stratification.

Scoring Criteria

ParameterLaboratory valuePoints
CRP<150 mg/L0
CRP≥150 mg/L4
WBC<15 ×10⁹/L0
WBC15–25 ×10⁹/L1
WBC>25 ×10⁹/L2
Hemoglobin>13.5 g/dL0
Hemoglobin11–13.5 g/dL1
Hemoglobin<11 g/dL2
Sodium≥135 mmol/L0
Sodium<135 mmol/L2
Creatinine≤141 µmol/L0
Creatinine>141 µmol/L2
Glucose≤10 mmol/L0
Glucose>10 mmol/L1

Score Interpretation

Total scoreRisk category
0–5Low risk category
6–7Intermediate risk category
8–13High risk category

These categories are score strata, not individualized probabilities and not a definitive diagnosis. Predictive values vary with disease prevalence, case mix, infection site, and study setting.

Evidence and Limitations

The original derivation study reported strong performance in its development and validation cohorts. Subsequent external studies and meta-analyses have shown substantially lower sensitivity in some settings.

  • In a 2019 meta-analysis, LRINEC ≥6 had pooled sensitivity of 68.2% and specificity of 84.8%; LRINEC ≥8 had sensitivity of 40.8% and specificity of 94.9%.
  • A prospective extremity cohort reported sensitivity of 43% at ≥6 and 27% at ≥8, with an AUROC of 0.696.
  • Performance may vary by anatomical site, patient population, timing of blood sampling, comorbidities, and comparator diagnosis.

Clinical Use

Use the score only as an adjunct in adults with suspected necrotizing soft-tissue infection. The original score is not established as a pediatric rule and should not be used as a stand-alone screening, diagnostic, or exclusion test.

Severe pain out of proportion, rapidly progressive infection, systemic toxicity, edema extending beyond erythema, bullae, ecchymosis, skin necrosis, or crepitus should prompt urgent clinical evaluation. Surgical consultation should not be delayed by a low score.

References

Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535–1541. DOI: 10.1097/01.CCM.0000129486.35458.7D. Original derivation and validation study.
Bechar J, Sepehripour S, Hardwicke J, Filobbos G. Laboratory risk indicator for necrotising fasciitis (LRINEC) score for the assessment of early necrotising fasciitis: a systematic review of the literature. Ann R Coll Surg Engl. 2017;99(5):341–346. DOI: 10.1308/rcsann.2017.0053. Review describing commonly used low, intermediate, and high score strata.
Fernando SM, Tran A, Cheng W, et al. Necrotizing Soft Tissue Infection: Diagnostic Accuracy of Physical Examination, Imaging, and LRINEC Score: A Systematic Review and Meta-Analysis. Ann Surg. 2019;269(1):58–65. DOI: 10.1097/SLA.0000000000002774. Diagnostic accuracy meta-analysis.
Hsiao CT, Chang CP, Huang TY, Chen YC, Fann WC. Prospective Validation of the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) Score for Necrotizing Fasciitis of the Extremities. PLoS One. 2020;15(1):e0227748. DOI: 10.1371/journal.pone.0227748. Prospective external validation cohort.
Karthikk R, Tandup C, Reddy D, et al. Prospective Validation and Comparison of LRINEC and SIARI Scoring Systems for Necrotizing Fasciitis. J Surg Res. 2023;283:719–725. DOI: 10.1016/j.jss.2022.11.001. Prospective validation and comparison study.
World Society of Emergency Surgery (WSES) / Surgical Infection Society Europe (SIS-E). 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections. World J Emerg Surg. 2018;13:58. DOI: Official article. Consensus guidance notes that laboratory tests are not highly sensitive or specific and LRINEC evidence is conflicting.
Infectious Diseases Society of America (IDSA). Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: Evaluation and Treatment of Necrotizing Fasciitis. 2014. Official guideline. Recommends prompt surgical consultation when necrotizing fasciitis is suspected.
Clinical disclaimer: This calculator is intended for healthcare professionals as an educational and decision-support aid. It does not establish or exclude necrotizing fasciitis and must not replace clinical assessment, urgent surgical consultation, imaging when appropriate, or operative exploration. Do not delay treatment while obtaining laboratory results or calculating the score. Always follow local protocols and specialist advice.